FMR »

Bioxcel Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by FMR from 13F filings

Historical chart of FMR investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2025-09-30 $508k 199k 2.56
2025-03-31 $22 11 2.00

More positions owned by FMR

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Ge Aerospace Com New (GE)
Wells Fargo & Company (WFC)

View all positions for FMR

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
FMR
Vanguard Group
Geode Capital Management
XTX Topco
BlackRock
State Street Corporation
UBS Group
Oaktree Fund Advisors
Northern Trust
Jones Financial Companies, L.L
HighTower Advisors
Foundations Investment Advisors
SLT Holdings

View all funds holding Bioxcel Therapeutics